Events Seminar: High-Efficiency Cell Engineering at IGI

Seminar: High-Efficiency Cell Engineering at IGI

Lunch and learn: Join us at Innovative Genomics Institute (IGI) for a high-efficiency cell engineering seminar

Wednesday, November 13, 2024

12:00 - 1:00 pm PT

If you are unable to attend in-person

In-Person Event Details

Location:
Innovative Genomics Institute (IGI)
2151 Berkeley Way
Berkeley, CA 94720

Join us for a Lunch and learn: high efficiency cell engineering presentation at the Innovative Genomics Institute (IGI). Don’t miss this unique opportunity to explore the future of cellular engineering! Gain valuable insights into MaxCyte’s cutting-edge electroporation platforms, which enable the efficient engineering of primary cells, keratinocytes, stem cells, and various other cell lines. Learn how our technology ensures high cell viability and optimal recovery rates for a wide range of applications, including CRISPR, cell-based assays, cell therapy manufacturing, viral production, and more.

Lunch is on us! We value your time, and to keep the focus on learning, we're providing a complimentary lunch for all on-site attendees. If you have any questions related to this event, please contact Genevieve Soares.

Speakers

Kimberly Hu

Manager & Junior Specialist, University of California, San Francisco

Kimberly Hu is the Lab manager in Aaron Twards Lab at UCSF. Her research focuses on understanding the pathogenesis of Squamous Cell Carcinoma and Merkel Cell Carcinoma. The Tward lab utilizes genome editing advances to model complex diseases and develop targeted therapies.

{"ARInfo":{"IsUseAR":false},"Version":"1.0.0","MakeupInfo":{"IsUseMakeup":false},"FaceliftInfo":{"IsChangeEyeLift":false,"IsChangeFacelift":false,"IsChangePostureLift":false,"IsChangeNose":false,"IsChangeFaceChin":false,"IsChangeMouth":false,"IsChangeThinFace":false},"BeautyInfo":{"SwitchMedicatedAcne":false,"IsAIBeauty":false,"IsBrightEyes":false,"IsSharpen":false,"IsOldBeauty":false,"IsReduceBlackEyes":false},"HandlerInfo":{"AppName":2},"FilterInfo":{"IsUseFilter":false}}

Ke Li, PhD

Head of PD and Assistant Researcher, University of California, San Francisco

Ke Li earned his PhD in Molecular Genetics from Albert Einstein College of Medicine. He completed his postdoctoral training with Dr. Yuh Nung Jan at Howard Hughes Medical Institute, leveraging surface proteomics to identify novel molecules regulating cellular fitness. Currently, he leads process development efforts at the UCSF’s Investigational Cellular Therapy program, focusing on integrating cutting-edge genome and epigenome engineering tools into non-viral platforms. Collaborating with both academic and industry partners, he is driving the development of next-generation cell therapies with enhanced safety and potency towards early-phase clinical trials.

Michelle Duong, PhD

Field Application Scientist, MaxCyte, Inc.

Michelle Duong is currently a field application scientist at MaxCyte supporting cell and gene therapy and protein production solutions for Bay Area customers from R&D to GMP settings. She previously worked as a field application scientist at Inscripta supporting a fully automated CRISPR platform that provided an end-to-end solution for gene engineering. And she also worked as a bench scientist at Synthego using CRISPR gene editing with their ECLIPSE platform. She conducted her doctoral studies at Cornell University, where she received a MS in Toxicology and a PhD in Bioengineering.

Genevieve Soares

Senior Business Development Manager, MaxCyte, Inc.

Genevieve joined the MaxCyte team in 2022 after 14 years at PeproTech, where she served scientists across the western US and Canada. As a Senior Business Development Manager in the Bay Area, she collaborates with industry and academic partners in cell and gene therapy, bioprocessing, and drug discovery. Passionate about scientific innovation, Genevieve is dedicated to empowering the scientific community in their quest to find cures for diseases.